Abstract:ImportancePsychotic experiences, such as hallucinations and delusions, are reported by approximately 5% to 10% of the general population, although only a small proportion develop psychotic disorders such as schizophrenia. Studying the genetic causes of psychotic experiences in the general population, and its association with the genetic causes of other disorders, may increase the understanding of their pathologic significance.ObjectivesTo determine whether genetic liability to psychotic experiences is shared with schizophrenia and/or other neuropsychiatric disorders and traits and to identify genetic loci associated with psychotic experiences.Design, Setting and ParticipantsAnalyses of genetic correlation, polygenic risk scores, and copy number variation were performed using data from participants in the UK Biobank from April 1, 2018, to March 20, 2019, to assess whether genetic liability to psychotic experiences is shared with schizophrenia and/or other neuropsychiatric disorders and traits. Genome-wide association studies of psychotic experience phenotypes were conducted to identify novel genetic loci. Participants in the final analyses after exclusions included 6123 individuals reporting any psychotic experience, 2143 individuals reporting distressing psychotic experiences, and 3337 individuals reporting multiple occurrences of psychotic experiences. A total of 121 843 individuals who did not report a psychotic experience formed the comparator group. Individuals with a psychotic disorder were excluded from all analyses.Main Outcomes and MeasuresGenetic associations with psychotic experience phenotypes.ResultsThe study included a total of 127 966 participants (56.0% women and 44.0% men; mean [SD] age, 64.0 [7.6] years). Psychotic experiences were genetically correlated with major depressive disorder, schizophrenia, autism spectrum disorder, and attention-deficit/hyperactivity disorder. Analyses of polygenic risk scores identified associations between psychotic experiences and genetic liability for major depressive disorder, schizophrenia, bipolar disorder, autism spectrum disorder, and attention-deficit/hyperactivity disorder. Individuals reporting psychotic experiences had an increased burden of copy number variations previously associated with schizophrenia (odds ratio [OR], 2.04; 95% CI, 1.39-2.98;P = 2.49 × 10−4) and neurodevelopmental disorders more widely (OR, 1.75; 95% CI, 1.24-2.48;P = 1.41 × 10−3). Genome-wide association studies identified 4 significantly associated loci, including a locus in Ankyrin-3 (ANK3[GenBankNM_020987]) (OR, 1.16; 95% CI, 1.10-1.23;P = 3.06 × 10−8) with any psychotic experience, and a locus in cannabinoid receptor 2 gene (CNR2[GenBankNM_001841]) (OR, 0.66; 95% CI, 0.56-0.78;P = 3.78 × 10−8) with distressing psychotic experiences. The genome-wide association study of any psychotic experience had a low single-nucleotide polymorphism–based heritability estimate (h2 = 1.71%; 95% CI, 1.02%-2.40%).Conclusions and RelevanceA large genetic association study of psychotic experiences from the population-based UK Biobank sample found support for a shared genetic liability between psychotic experiences and schizophrenia, major depressive disorder, bipolar disorder, and neurodevelopmental disorders.

Associations Between Genetic Risk, Physical Activities, and Distressing Psychotic-like Experiences

Exposure profiles of social-environmental neighborhood factors and psychotic-like experiences

Polygenic liability for schizophrenia and childhood adversity influences daily-life emotion dysregulation and psychosis proneness

Independent and joint effects of genomic and exposomic loads for schizophrenia on distressing and persisting psychotic experiences in adolescence

Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits

Patterns of stressful life events and polygenic scores for five mental disorders and neuroticism among adults with depression

The Moderating Role of Genetic and Environmental Risk Factors for Schizophrenia on the Relationship between Autistic Traits and Psychosis Expression in the General Population

O8.1. ASSOCIATION BETWEEN GENETIC AND ENVIRONMENTAL RISK FOR SCHIZOPHRENIA DURING UPBRINGING: FINDINGS FROM A LONGITUDINAL COHORT STUDY

The effect of polygenic risk score and childhood adversity on transdiagnostic symptom dimensions at first-episode psychosis: evidence for an affective pathway to psychosis

Gene–environment pathways to cognitive intelligence and psychotic-like experiences in children

Attention-mediated genetic influences on psychotic symptomatology in adolescence

Exposome-wide gene-environment interaction study of psychotic experiences in the UK Biobank

Examining the association between prenatal and perinatal adversity and the psychotic experiences in childhood

Childhood Adversity and Emerging Psychotic Experiences: A Network Perspective

The association between neighborhood-level social fragmentation and distressing psychotic-like experiences in early adolescence: the moderating role of close friends

Longitudinal Trajectories of Psychotic-Like Experiences and Their Relationship to Emergent Mental Disorders among Adolescents: A 3-Year Cohort Study

Polygenic and Polyenvironment Interplay in Schizophrenia-Spectrum Disorder and Affective Psychosis; the EUGEI First Episode Study

Polygenic risk scores mediating functioning outcomes through cognitive and clinical features in youth at family risk and controls

Interplay between polygenic risk for mood disorders and stressful life events in bipolar disorder

Schizophrenia polygenic risk is associated with child mental health problems through early childhood adversity: evidence for a gene–environment correlation